KBC Group’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
KBC Group's DFTX Position: Q3 2026 in Review
KBC Group held its Definium Therapeutics (DFTX) position steady in Q3 2026 at 3,310 shares worth $126K. The position accounts for ﹤0.01% of the portfolio, ranked #1259.
KBC Group first reported a position in DFTX in Q1 2026 and has held it in 3 quarters since. The position peaked at $156K in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- KBC Group held 3,310 shares of Definium Therapeutics worth $126K as of Q3 2026.
- KBC Group left its Definium Therapeutics share count unchanged in Q3 2026.
- Definium Therapeutics made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1259 holding.
- KBC Group first reported a position in Definium Therapeutics in Q1 2026 and has held it in 3 quarters since.
- KBC Group's Definium Therapeutics position peaked at $156K in Q2 2026.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.